We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PARNF market cap is 120.38. The company's latest EPS is AUD -0.0477 and P/E is 0.00.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 26.69M | 28.99M | 30M | 34.34M | 35.43M |
| Operating Income | 3.41M | 2.98M | 3.15M | 3.6M | 2.5M |
| Net Income | 130k | -7.18M | -15.06M | -1.42M | -5.74M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 33.48M | 39.04M | 40.58M | 40.11M | 41.78M |
| Total Liabilities | 52.01M | 65.26M | 72.43M | 74.9M | 89.77M |
| Total Equity | -18.53M | -26.23M | -31.86M | -34.79M | -48M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.62M | 2.27M | -4.76M | 5.45M | 2.36M |
| Investing | -2.76M | -2.74M | -3.35M | -4.17M | -6.62M |
| Financing | 6.16M | 993k | 9.43M | 67k | 2M |
| Market Cap | 120.38 |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 120.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -99.00% |
| 52 Week High | 0.0001 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Parnell Pharmaceuticals Holdings Ltd (CE) |
| Address |
unit 4 century estate sydney, new south wales 2015 |
| Website | https://www.parnell.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
